IR-Med Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Ran Ziskind

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	less than a year
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	3.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.8yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Ran Ziskind

less than a year

Amtszeit

Mr. Ran Ziskind is Chief Executive Officer of IR-Med Inc. from September 1, 2024. Mr. Ziskind is a highly experienced high-tech innovator and company leader with two decades of expertise in launching, deve...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Oded Bashan	Co-Founder & Chairman	11.1yrs	US$273.73k	12.16% $ 4.6m
Aharon Klein	Co-Founder	11.1yrs	US$101.07k	11.1% $ 4.2m
Aharon Binur	Chief Development Officer	3.5yrs	US$252.67k	0% $ 0
Ran Ziskind	Chief Executive Officer	less than a year	keine Daten	keine Daten
Yaniv Cohen	Co-Founder	1.8yrs	keine Daten	11.1% $ 4.2m
Sharon Levkoviz	CFO, Treasurer & Secretary	3.8yrs	keine Daten	0% $ 0
Avi Vachnis	Head of Software & AI	3.3yrs	keine Daten	keine Daten

3.5yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrenes Management: IRMEDas Führungsteam des Unternehmens gilt als erfahren (3.5 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Oded Bashan	Co-Founder & Chairman	11.1yrs	US$273.73k	12.16% $ 4.6m
Aharon Klein	Co-Founder	11.1yrs	US$101.07k	11.1% $ 4.2m
Yaniv Cohen	Co-Founder	3.8yrs	keine Daten	11.1% $ 4.2m
Ohad Bashan	Director	3.8yrs	keine Daten	0% $ 0
Richard Serbin	Member of Advisory Board	1.1yrs	keine Daten	keine Daten
Ron Mayron	Independent Director	3.8yrs	US$78.50k	0% $ 0
David Levy	Director of IR-Med Ltd	9.7yrs	keine Daten	keine Daten
Lynn Eschenbacher	Member of Advisory Board	no data	keine Daten	keine Daten
Avital Rosenberg	Independent Director	less than a year	keine Daten	keine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

62yo

Durchschnittliches Alter

Erfahrener Vorstand: IRMEDie Vorstandsmitglieder gelten als erfahren (3.7 Jahre durchschnittliche Amtszeit).

IR-Med Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

Recent updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

IR-Med Inc. has filed an IPO in the amount of $8 million.

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc.’s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Hmo

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

IR-Med Inc., Annual General Meeting, Dec 12, 2022

IR-Med Announces Appointment of Moshe Gerber as Chief Executive Officer

International Display Advertising, Inc. (OTCPK:IDAD.D) completed the acquisition of IR Med, Ltd.

International Display Advertising, Inc. announced that it expects to receive $5 million in funding

Geschäftsführer

Amtszeit

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter